OBJECTIVE: Cardiopulmonary bypass elicits systemic inflammation. Depletion of circulating leukocytes might alleviate inflammatory response. We studied the effects of a leukocyte-depleting filter on phagocyte activation during cardiopulmonary bypass. METHODS:Fifty patients undergoing coronary artery bypass grafting were randomly allocated into an arterial line leukocyte filter group (n = 25) with a Pall LeukoGuard 6 leukocyte-depleting filter (LG6; Pall Biomedical, Portsmouth, United Kingdom) and a control group without any filter (n = 25). Blood sampling took place from arterial line at predetermined time points. In the filter group, the sample was taken immediately before the filter; to evaluate activation at the site, an additional sample was taken immediately after the filter. CD11b/CD18 and L-selectin expressions and basal production of hydrogen peroxide were determined with whole-blood flow cytometry, and plasma lactoferrin level was determined with enzyme-linked immunosorbent assay. RESULTS:NeutrophilCD11b expression was higher in the filter group than in the control group (P < .001). Likewise, monocyte CD11b expression, neutrophil hydrogen peroxide production, and lactoferrin plasma levels were all significantly higher, whereas neutrophil and monocyte counts and neutrophil L-selectin expression were all significantly lower in the filter group (all P < .001). At 5 minutes of CPB, CD11b expression increased across the filter on neutrophils (median difference 197 relative fluorescence units, range 45-431 relative fluorescence units, P < .001) and monocytes (median difference 26 relative fluorescence units, range -68-111 relative fluorescence units, P < .001). CONCLUSION: The LG6 arterial line leukocyte filter is ineffective in its principal task of diminishing phagocyte activation during cardiopulmonary bypass.
RCT Entities:
OBJECTIVE: Cardiopulmonary bypass elicits systemic inflammation. Depletion of circulating leukocytes might alleviate inflammatory response. We studied the effects of a leukocyte-depleting filter on phagocyte activation during cardiopulmonary bypass. METHODS: Fifty patients undergoing coronary artery bypass grafting were randomly allocated into an arterial line leukocyte filter group (n = 25) with a Pall LeukoGuard 6 leukocyte-depleting filter (LG6; Pall Biomedical, Portsmouth, United Kingdom) and a control group without any filter (n = 25). Blood sampling took place from arterial line at predetermined time points. In the filter group, the sample was taken immediately before the filter; to evaluate activation at the site, an additional sample was taken immediately after the filter. CD11b/CD18 and L-selectin expressions and basal production of hydrogen peroxide were determined with whole-blood flow cytometry, and plasma lactoferrin level was determined with enzyme-linked immunosorbent assay. RESULTS: Neutrophil CD11b expression was higher in the filter group than in the control group (P < .001). Likewise, monocyte CD11b expression, neutrophil hydrogen peroxide production, and lactoferrin plasma levels were all significantly higher, whereas neutrophil and monocyte counts and neutrophil L-selectin expression were all significantly lower in the filter group (all P < .001). At 5 minutes of CPB, CD11b expression increased across the filter on neutrophils (median difference 197 relative fluorescence units, range 45-431 relative fluorescence units, P < .001) and monocytes (median difference 26 relative fluorescence units, range -68-111 relative fluorescence units, P < .001). CONCLUSION: The LG6 arterial line leukocyte filter is ineffective in its principal task of diminishing phagocyte activation during cardiopulmonary bypass.
Authors: Terry C Major; Elizabeth J Brisbois; Anna M Jones; Margaux E Zanetti; Gail M Annich; Robert H Bartlett; Hitesh Handa Journal: Biomaterials Date: 2014-06-10 Impact factor: 12.479
Authors: Terry C Major; David O Brant; Charles P Burney; Kagya A Amoako; Gail M Annich; Mark E Meyerhoff; Hitesh Handa; Robert H Bartlett Journal: Biomaterials Date: 2011-06-22 Impact factor: 12.479
Authors: Terry C Major; David O Brant; Melissa M Reynolds; Robert H Bartlett; Mark E Meyerhoff; Hitesh Handa; Gail M Annich Journal: Biomaterials Date: 2009-12-29 Impact factor: 12.479
Authors: Catalin S Buhimschi; Vineet Bhandari; Benjamin D Hamar; Mert-Ozan Bahtiyar; Guomao Zhao; Anna K Sfakianaki; Christian M Pettker; Lissa Magloire; Edmund Funai; Errol R Norwitz; Michael Paidas; Joshua A Copel; Carl P Weiner; Charles J Lockwood; Irina A Buhimschi Journal: PLoS Med Date: 2007-01 Impact factor: 11.069
Authors: S M Muro; J H Lee; J V Stokes; M K Ross; T M Archer; R W Wills; A J Mackin; J M Thomason Journal: J Vet Intern Med Date: 2017-01-31 Impact factor: 3.333